MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$25,350K
EPS
-$0.4
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
-
-
11,038
-
Cost of revenues
-
-
2,388
-
Revenue
0
-
-
-
Research and development
16,057
19,983
21,711
17,808
General and administrative
9,933
4,377
5,234
5,653
Total costs and operating expenses
-
-
29,333
23,461
Total operating expenses
25,990
24,360
-
-
Loss from operations
-25,990
-24,360
-18,295
-23,461
Interest and investment income, net
255
457
600
774
Sublease income
389
631
692
684
Total other income, net
644
1,088
1,292
1,458
Loss before income taxes
-25,346
-
-17,569*
-22,003
Income tax expense
0
-
537*
-
Net loss
-25,346
-23,272
-18,106
-22,003
Net unrealized loss on marketable debt securities
-4
-53
-16
74
Other comprehensive loss
-4
-53
-16
74
Comprehensive loss
-25,350
-23,325
-18,122
-21,929
Basic EPS
-0.4
-0.37
-0.287
-0.35
Diluted EPS
-0.4
-0.37
-0.287
-0.35
Basic Average Shares
63,991,609
63,469,850
63,047,504
62,557,386
Diluted Average Shares
63,991,609
63,469,850
63,047,504
62,557,386
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$25,350K
(-37.71%↓ Y/Y)
Net loss
-$25,346K
(-38.10%↓ Y/Y)
Other comprehensive
loss
-$4K
(92.59%↑ Y/Y)
Sublease income
$389K
(-43.13%↓ Y/Y)
Interest and investment
income, net
$255K
(-74.37%↓ Y/Y)
Loss before income
taxes
-$25,346K
(-40.26%↓ Y/Y)
Net unrealized loss
on marketable debt...
-$4K
(92.59%↑ Y/Y)
Total other income,
net
$644K
(-61.64%↓ Y/Y)
Loss from operations
-$25,990K
(-31.59%↓ Y/Y)
Total operating
expenses
$25,990K
Research and development
$16,057K
(-6.28%↓ Y/Y)
General and
administrative
$9,933K
(82.69%↑ Y/Y)
Buy us a coffee
Pyxis Oncology, Inc. (PYXS)
Pyxis Oncology, Inc. (PYXS)